Market Overview:

The global market for Infusion pumps estimated at USD 13156.28 Million in 2023 is projected to reach a revised size of USD 22030.89 Million by 2030, growing at a CAGR of 9.10% over the period 2023-2030.

The market is gaining significant traction after introduction of insulin pump by leading market players such as Medtronic, Insulet Corporation etc. The market is projected to expand at considerable growth rate owing to the key factors such as growing prevalence of chronic diseases, advancements in drug delivery technologies, and increasing adoption of these techniques in the emerging regions. This pump is a medical device used to deliver fluids such as nutrients and medicines to the patient in a controlled amount. These are designed based on the specialized functions such as enteral feeding pumps to deliver nutrients, insulin pumps to deliver insulin, and patient controlled analgesia (PCA) pumps for delivery of pain medications. Various routes utilized for fluid delivery by these pumps include intravenous, subcutaneous, and arterial. The practice of these pumps has been encouraged over the manually driven flow control method to provide accurate and exact delivery of the fluid and achieve therapeutic efficacy.

Top Key Players Covered in The Infusion Pump Market:

• • Medtronic (Ireland)
  • Becton Dickinson and Company (U.S.)
  • Baxter (U.S.)
  • Insulet Corporation (U.S.)
  • ICU Medical, Inc. (U.S.)
  • Braun Melsungen AG (Germany)
  • Smiths Medical (Smiths Group plc.) (U.S.)
  • Fresenius Kabi AG (Germany)
  • Terumo Corporation (Japan)
  • Hoffmann-La Roche Ltd (Switzerland)
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), and Other Major Players

Market Dynamics and Factors:           

Continuous advancements in infusion pump technology, such as the development of smart pumps, wireless connectivity, and improved software integration, are driving market growth. These technological innovations enhance safety, accuracy, and efficiency in medication delivery, leading to increased adoption by healthcare facilities. The growing prevalence of chronic diseases requiring long-term medication administration, such as diabetes, cancer, and cardiovascular disorders, is a significant driver of the infusion pump market. The need for precise and controlled drug delivery methods fuels the demand for infusion pumps across various healthcare settings.

The global aging population is a key driver as elderly individuals often require complex medication regimens and continuous monitoring, driving the demand for infusion pumps in geriatric care and home healthcare settings. The trend toward ambulatory care and outpatient settings is driving the adoption of portable and wearable infusion pumps, providing patients with greater mobility and convenience while receiving treatment.

 The Infusion Pump Market Report Highlight:

• • By Type, the market is segmented into volumetric pumps, syringe pumps, enteral feeding pumps, insulin pumps, elastomeric pumps, implantable pumps, and patient control analgesia (PCA) pumps. Globally the insulin pump segment dominated the global market. The segment is projected to continue its dominance by expanding at a significantly high growth rate during the forecast period. This is attributable to the growing number of type 1 diabetic patient population globally and the introduction of promising technologies in the insulin pump area.
  • By Application, market segments include diabetes, oncology, pain management, and others. Among them, the diabetes segment held largest infusion pump market share in the year 2020. The segment is estimated to grow at highest CAGR during the forecast period. The oncology segment is expected to witness significant traction owing to the growing prevalence of various cancers and increasing new product launches in this area. Other application areas of this pump include gastroenterology, hematology, pediatrics, and anesthesia, blood transfusion, and others.
  • By Region, The market in the region in characterized by higher diagnosis and treatment rates for diabetes coupled with high adoption of ambulatory pumps, and favorable reimbursement policies in the region. Technological advancement related to the medical devices in the North America region is boosting the growth of the region. Europe held second largest share of the market. An increase in the prevalence of chronic diseases in this region and significant expenditure in the healthcare sector by the European Commission are anticipated to drive the demand for these pumps.

 Key Industry Development:

In August 2023, ICU Medical, Inc. (US) received FDA clearance for its Plum Duo infusion pump, which will make it available for customers in the US in early 2024.

In April 2023, Fresenius Kabi (Germany) announced that its Ivenix Infusion System has received an Innovative Technology contract from Vizient, Inc. (US), which sets terms for hospitals to evaluate and purchase the Ivenix Infusion System.

The Infusion Pump Market Segmentation:

By Type

• • Volumetric Pumps
  • Syringe Pumps
  • Elastomeric Pumps
  • Insulin Pumps
  • Enteral Pumps
  • Implantable Pumps
  • Patient Control Analgesia (PCA) Pumps

 By Application

• • Diabetes
  • Oncology
  • Pain Management
  • Others

By End User

• • Hospitals
  • Ambulatory Care Settings
  • Specialty Clinics
  • Home Care Settings

For this report, Pristine Intelligence Research has segmented the Infusion Pump Market based on region:

North America

• • The U.S.
  • Canada
  • Mexico

Eastern Europe

• • Russia
  • Bulgaria
  • The Czech Republic
  • Hungary
  • Poland
  • Romania
  • Rest of Eastern Europe

Western Europe

• • Germany
  • UK
  • France
  • Netherlands
  • Italy
  • Spain
  • Rest of Western Europe

Asia Pacific

• • China
  • India
  • Japan
  • Singapore
  • Australia
  • New-Zealand
  • Rest of APAC

Middle East & Africa

• • Turkey
  • Saudi Arabia
  • Qatar
  • UAE
  • Israel
  • South Africa

South America

• • Brazil
  • Argentina
  • Rest of SA